Literature DB >> 15028850

Secondary skeletal involvement in Sanfilippo syndrome.

D Rigante1, P Caradonna.   

Abstract

BACKGROUND: Sanfilippo syndrome, or mucopolysaccharidosis (MPS) type III, is a rare lysosomal storage disease, resulting from errors in the catabolism of heparan sulphate. AIM: To evaluate bone turnover and bone mineral density (BMD) in MPS type III patients.
DESIGN: Clinical and observational study.
METHODS: We evaluated serum markers of bone formation or resorption, and measured BMD using dual-energy X-ray absorptiometry (DEXA), in three patients with MPS type III.
RESULTS: Serum vitamin D were low, and BMDs greatly reduced at lumbar and femoral sites, indicating the possibility of osteoporosis and osteomalacia. DISCUSSION: These skeletal effects probably result from nutritional deficiencies and inability to walk, rather than from the genetic defect itself. Secondary skeletal involvement in patients with MPS type III may represent a considerable cause of morbidity, and requires interventions to reduce the risk of pathological fractures.

Entities:  

Mesh:

Year:  2004        PMID: 15028850     DOI: 10.1093/qjmed/hch041

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  11 in total

1.  Bone density assessment in patients with mucopolysaccharidosis: A preliminary report from patients with MPS II and VI.

Authors:  Ellen B Fung; Jo Ann Johnson; Jacqueline Madden; Tiffany Kim; Paul Harmatz
Journal:  J Pediatr Rehabil Med       Date:  2010

2.  Potential role of cathepsin K in the pathophysiology of mucopolysaccharidoses.

Authors:  Susan Wilson; Dieter Brömme
Journal:  J Pediatr Rehabil Med       Date:  2010

3.  A Case of Sanfillippo's Disease Correlating Clinical and Biochemical Findings.

Authors:  Priyanka Datta; Anushre Prasad; Vijetha Shenoy; Shrikiran Hebbar; Suneel C Mundkur; Pragna Rao
Journal:  Indian J Clin Biochem       Date:  2014-01-31

4.  Bone mineral density in patients with mucopolysaccharidosis type III.

Authors:  Banu Guzel Nur; Hakan Nur; Ercan Mihci
Journal:  J Bone Miner Metab       Date:  2016-05-18       Impact factor: 2.626

5.  Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases.

Authors:  Calogera M Simonaro; Marina D'Angelo; Xingxuan He; Efrat Eliyahu; Nataly Shtraizent; Mark E Haskins; Edward H Schuchman
Journal:  Am J Pathol       Date:  2007-12-13       Impact factor: 4.307

Review 6.  Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.

Authors:  Hira Peracha; Kazuki Sawamoto; Lauren Averill; Heidi Kecskemethy; Mary Theroux; Mihir Thacker; Kyoko Nagao; Christian Pizarro; William Mackenzie; Hironori Kobayashi; Seiji Yamaguchi; Yasuyuki Suzuki; Kenji Orii; Tadao Orii; Toshiyuki Fukao; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2018-05-15       Impact factor: 4.797

7.  Diagnosis of Sanfilippo disease correlating clinical, radiological and biochemical findings-a case report.

Authors:  Udit Agrawal; Ajay Meshram; Jayant Vagha; Kirti Swarnkar; Kamlesh Palandurkar
Journal:  Indian J Clin Biochem       Date:  2012-05-03

8.  Genetic regulation of bone metabolism in the chicken: similarities and differences to Mammalian systems.

Authors:  Martin Johnsson; Kenneth B Jonsson; Leif Andersson; Per Jensen; Dominic Wright
Journal:  PLoS Genet       Date:  2015-05-29       Impact factor: 5.917

9.  Assessment of bone mineral density by dual energy x-ray absorptiometry in patients with mucopolysaccharidoses.

Authors:  Hsiang-Yu Lin; Shou-Chuan Shih; Chih-Kuang Chuang; Ming-Ren Chen; Dau-Ming Niu; Shuan-Pei Lin
Journal:  Orphanet J Rare Dis       Date:  2013-05-11       Impact factor: 4.123

10.  Bisphosphonate Treatment in a Patient Affected by MPS IVA with Osteoporotic Phenotype.

Authors:  Albina Tummolo; Orazio Gabrielli; Alberto Gaeta; Maristella Masciopinto; Lucia Zampini; Luigi Michele Pavone; Paola Di Natale; Francesco Papadia
Journal:  Case Rep Med       Date:  2013-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.